(Q33736837)

29 July 2017

1 reference

title

Treatment changes in prostatic hyperplasia and cancer, including androgen deprivation therapy and radiotherapy (English)

1 reference

29 July 2017

main subject

prostatic hypertrophy

1 reference

1

Bostwick DG

1 reference

29 July 2017

Ramnani D

2

1 reference

29 July 2017

Cheng L

series ordinal

3

1 reference

29 July 2017

publication date

1 August 1999

1 reference

Urologic Clinics of North America

29 July 2017

published in

1 reference

29 July 2017

volume

26

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

465-479

1 reference

Assessment of prostate carcinoma in core needle biopsy--definition of minimal criteria for the diagnosis of cancer in biopsy material

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Treatment with finasteride following radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

High grade prostatic intraepithelial neoplasia in prostates removed following irradiation failure in the treatment of prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Clinical and Pathobiological Effects of Neoadjuvant Total Androgen Ablation Therapy on Clinically Localized Prostatic Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Clear cell cribriform hyperplasia of prostate. Report of 10 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Combined histologic grading of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Radiation injury of the normal and neoplastic prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Minimal criteria for the diagnosis of prostate cancer on needle biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Molecular biology of prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Evaluating prostate needle biopsy: therapeutic and prognostic importance

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Androgen receptor mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Accuracy of biopsy Gleason scores from a large uropathology laboratory: use of a diagnostic protocol to minimize observer variability

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Postatrophic hyperplasia of the prostate. A histologic mimic of prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Leuprorelin. A review of its pharmacology and therapeutic use in prostatic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Biopsy after External Beam Radiation Therapy for Adenocarcinoma of the Prostate: Correlation with Original Histological Grade and Current Prostate Specific Antigen Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Design of the Prostate Cancer Prevention Trial (PCPT).

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Treatment of advanced prostate cancer with the combination of finasteride plus flutamide: early results.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Minimal or no cancer in radical prostatectomy specimens. Report of 13 cases of the "vanishing cancer phenomenon".

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

The histology of radiation therapy effect on prostate adenocarcinoma as assessed by needle biopsy after brachytherapy boost. Correlation with biochemical failure

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

The effect of finasteride on prostate specific antigen: review of available data

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Boost treatment of the prostate using shaped, fixed fields

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Analysis of independent variables affecting survival after recurrence of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Histopathological changes in androgen-deprived localized prostatic cancer. A study in total prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Histological and immunohistochemical findings of prostatic carcinoma after external or interstitial radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Current clinical studies with a new nonsteroidal antiandrogen, Casodex

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Androgen receptor alterations in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first-line therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Response of rat and human prostatic cancers to the novel 5 alpha-reductase inhibitor, SK&F 105657

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Androgen receptor expression in prostatic dysplasia (prostatic intraepithelial neoplasia) in the human prostate: an immunohistochemical and in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Management of radiation failure for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Immunohistochemical evaluation of prostatic carcinoma before and after radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Gleason histologic grading of prostatic carcinoma. Correlations between biopsy and prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Apoptotic bodies in prostatic intraepithelial neoplasia and prostatic adenocarcinoma following total androgen ablation.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Treatment of benign prostatic hyperplasia with 5-alpha-reductase inhibitor: morphological changes in patients who fail to respond

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Pathologic changes associated with androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Antiandrogens alone or in combination for treatment of prostate cancer: the European experience

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Salvage surgery for radiation failure in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Predictors of survival after a positive post-irradiation prostate biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

The clinical significance of a positive post-irradiation prostatic biopsy without metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

p53 immunohistochemical and genetic alterations are associated at high incidence with post-irradiated locally persistent prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

1 reference

7 January 2021

Histological characteristics of prostatic biopsies after 125iodine implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Hormone-refractory (D3) prostate cancer: refining the concept.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Histologic changes of irradiated prostatic carcinoma diagnosed by transrectal ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Histologic changes in prostate carcinomas treated with leuprolide (luteinizing hormone-releasing hormone effect). Distinction from poor tumor differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Antiandrogenic agents as monotherapy in advanced prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

The clinical development of a 5α-reductase inhibitor, finasteride

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Clinical experience of the detection of prostate cancer in patients with benign prostate hyperplasia treated with finasteride. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Active cell death in hormone-dependent tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Effect of combination endocrine therapy (LHRH agonist and flutamide) on normal prostate and prostatic adenocarcinoma. A histopathologic and immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Chemoprevention of rat prostate carcinogenesis by use of finasteride or casodex

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Effect of 5-alpha-reductase inhibition and dexamethasone administration on the growth characteristics and intratumor androgen levels of the human prostate cancer cell line PC-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Endocrine profiles during administration of the new non‐steroidal anti‐androgen Casodex in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Dedifferentiation of locally recurrent prostate cancer after radiation therapy. Evidence for tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970195-6

7 January 2021

10.1016/S0094-0143(05)70195-6

Identifiers

DOI

1 reference

29 July 2017

1 reference